Introduction
The polymorphonuclear leukocyte is a major target for the action of bacterial endotoxin (lipopolysaccharide, LPS). LPS in concentrations as low as 1.0 ng/ml has been shown to "prime" human neutrophils for an enhanced respiratory burst in response to the chemoattractant peptide FMLP, or opsonized zymosan (OZ; ' 1) . This concentration of endotoxin is similar to that found in patients with septic shock (2) . More recently it has been shown that endotoxin in similar concentrations can prime the mouse peritoneal macrophage for enhanced release of eicosanoids, an event felt to be of significance in the response to bacterial infection (3) .
The primary product of arachidonic acid metabolism in human neutrophils is leukotriene B4 (LTB4) or 5(s), 12(r)-di-water bath according to the method of Guthrie et al. (1) . In most experiments 1 ml of the cell mixture was used. 4 ml ofthe cell mixture was used to increase the sensitivity of the assay methods in one group of experiments using OZ as a stimulant for LTB4 production. An incubation time of60 min was used in initial experiments based on the previously reported optimal incubation time for priming for enhanced superoxide generation (1, 15) . Subsequently experiments were performed with the incubation times varied to determine the optimum duration of LPS exposure. After incubation, cells were examined microscopically to be certain that clumping had not occurred. Trypan blue exclusion always showed the neutrophils to be > 92% viable after incubation. Superoxide production was determined concurrently in some experiments to verify LPS priming of the respiratory burst as previously reported (1, 15) . Superoxide was measured using a cytochrome c assay as previously described (15) .
Preparation of reagents. Ionophore A23187 (Ionophore; Calbiochem-Behring Corp., La Jolla, CA) was reconstituted from powder in ethanol and sonicated at maximal output for 2 min and then stored at -20'C. On the day of use the ionophore was again sonicated, diluted to final concentration in HBSS (-), and sonicated again.
Phorbol myristate acetate (PMA; Sigma Chemical Co., St. Louis, MO) was stored in initial stock solution (1 mg/ml) in dimethyl sulfoxide (DMSO; Sigma Chemical Co.) at -20'C. On the day of use the PMA stock solution was diluted to the desired concentration with HBSS (-).
OZ was prepared by first boiling zymosan (Sigma Chemical Co.) in 0.9% NaCl to get a suspension free ofclumping ofthe particles. This is cooled to room temperature and washed four times in sterile saline then incubated with fresh human serum at 370C for 20 min (Lab-Line Instruments, Melrose Park, IL; 16). After centrifugation and four washings the OZ was suspended in 0.9% NaCI at 50 mg/ml. FMLP (Sigma Chemical Co.) was stored at -70'C in HBSS (-) and 10% DMSO at a final concentration of0.1 mM. On the day ofuse the FMLP stock solution was diluted to the desired concentration with HBSS (-).
Fura 2/AM (Calbiochem) was stored at -20'C in DMSO at a final concentration of 10 mM.
Stimulation ofprimed cellsfor LTB4 generation. After the incubation with LPS, calcium and magnesium salts were added to the cell suspension in the concentrations necessary to achieve a final solution equivalent to HBSS (+). Ionophore, OZ, PMA, or FMLP was then added, and the cell mixture was incubated for the desired time. The concentration of DMSO never exceeded 0.01%, and the concentration of ethanol was never greater than 0.01% in the final solution. The mixture was vortexed frequently to maintain the cells in suspension. Incubations were terminated in most experiments with the addition of 1.5 volumes of iced ethanol (HPLC grade; Aldrich Chemical Co., Milwaukee, WI) and the mixture refrigerated at -200C for at least I h. Intracellular and extracellular LTB4 were determined in the experiments using 4 ml of the neutrophil suspension and OZ as the second stimulant. The incubation was terminated by cooling at 4°C and centrifugation at 500 g. The supernatant was decanted and the cell pellet resuspended in 100% methanol (HPLC grade; Burdick-Jackson Laboratories, Muskegon, MI) for 12 h at 4°C (17) . Prostaglandin B2 (200 mg; Sigma Chemical Co.) was added as an internal standard to all experiments ( 18) .
Extraction of eicosanoids. Polypropylene labware was used throughout the extraction process to avoid losses of the eicosanoids to glass surfaces. The cell mixture was centrifuged at 500 g (Accuspin; Beckman Instruments, San Ramon, CA) and the supernatant extracted on octadecyl-silane (ODS) C18 cartridges (Sep-pak; Waters Associates, Milford, MA; 18). Individual cartridges were prepared with 20 ml of ethanol followed by 5 12 (s)-dihydroxy-6,14-cis-8, I0-trans-eicosatetraenoic acid (20) was ruled out by chromatography of the methyl esters using the above system with an ultrasphere Si (Beckman) column (4.7 mm X 250 mm) and precolumn (4.7 mm X 45 mm) with 5-,um bead size. Isocratic elution with hexane/2-propanol at 2.0 ml/min was performed as previously described (18, 21, 22) . 5,12,DiHete never exceeded 3% oftotal LTB4.
Experiments were performed using four times the number of neutrophils to increase the sensitivity of the assay system for OZ stimulated LTB4 production. The LTB4 and metabolite peaks eluting from the HPLC were collected and further analyzed by ultraviolet spectroscopy (model HP 89500; Hewlett-Packard Corp., Palo Alto, CA) and found to have peak absorption at 270 nm with shoulders at 260 and 280 nm as previously described (20) . In addition, a portion of the collected peak eluting as LTB4 was further characterized and quantitated as LTB4 by radioimmunoassay (LTB4 antisera; Advanced Magnetics, Cambridge, MA) Spectrofluorimetric analysis of intracellular calcium. Neutrophils were loaded with Fura 2 by addition of I gM Fura 2/AM to the cell suspension (1 X 107 cells/ml) for 1 h at 37°C in a shaking water bath (23) . After incubation the cells were centrifuged at 200 g for 10 min to remove extracellular dye and resuspended in HBSS (-). After loading the cell mixture was divided and portions analyzed fluorimetrically or incubated for 60 min without LPS or with LPS 10 ng/ml. Following this incubation the mixture was again centrifuged at 200 g for 10 min and the supernatant decanted to remove any Fura 2 that may have leaked from the cells during the priming process. The cell mixture was then analyzed for baseline calcium concentration and followed by the addition of calcium and magnesium salts necessary to achieve a final solution equivalent to HBSS (+). After In addition to finding a difference in the amounts and rates of release of LTB4 and metabolites there was a marked difference in the ratio of LTB4 to metabolites between LPS-primed and unprimed neutrophils. The LTB4 produced by cells incubated in the absence of LPS was almost entirely comprised of metabolites with a maximum of 15% being LTB4 even at the earliest time points. In contrast, cells incubated in the presence of LPS (10 ng/ml) released up to 50% of the total as LTB4 before metabolism (Fig. 2) .
Human neutrophils maximally produce LTB4 in response to ionophore at a concentration of 1.0 ,ug/ml (26) . At 
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-Mresulted in production of 2.8±0.8 ng/106 cells (Fig. 3) . The LPS-primed neutrophils produced native as well as metabolized LTB4 (Fig. 4) . The lowest concentration ofLPS necessary to result in enhanced production of LTB4 under these conditions was 0.1 ng/ml. Intracellular retention of native LTB4 was not found in experiments designed to differentiate cell associated from secreted LTB4. This is in contrast to what has been previously described for neutrophils stimulated with unopsonized zymosan (17) and does not appear to be the reason for the absence of native LTB4 from the unprimed neutrophils.
FMLP does not cause LTB4 production by neutrophils in the absence of exogenous arachidonate (25, 26) . Priming with LPS in concentrations ranging from 0.01 to 100 ng/ml, did not result in the production of detectable amounts of LTB4 or metabolites by neutrophils incubated with FMLP 10-6 M for up to 60 min.
PMA, which is reported to act via enhanced activity of protein kinase C (27, 28), has been reported to prime neutrophils for enhanced production of LTB4 (29, 30) . Stimulation with PMA (1 lg/ml) alone for up to 5-10 min however was not sufficient for LTB4 production in these and other experiments (25, 29, 30) . We found that incubating neutrophils with PMA (1 lg/ml) for as long as 60 min did not result in production of LTB4 or metabolites. Significant amounts of LTB4 metabolites were however, detectable from neutrophils preincubated with LPS and then stimulated with PMA (Table I ). The duration of incubation with PMA in these experiments was 60 min. All of 3.Or the LTB4 detected was present as the metabolites. The lowest concentration of LPS necessary to consistently produce this effect is 0.1 ng/ml.
OZ effects on intracellular calcium in primed and unprimed neutrophils. Calculated intracellular calcium concentrations immediately after the incubation period with Fura 2/AM were essentially zero. Following the addition of calcium to the mixture the concentration rose to 40 nM in both control and LPS-treated cells. Upon addition of zymosan to the mixture there was a rise in the calcium levels plateauing at 90-120 s (Fig. 5) . This is consistent with previously reported data (31). There was no significant difference in baseline calcium or cal- Table I . Effect ofLPS on PMA (I gtg/ml) Induced Production ofLTB4 and Metabolites by Neutrophils 30 1 TIME (minutes) Figure 3 . Effect of LPS on OZ (10 mg/ml) induced production of LTB4 and metabolites by neutrophils. Neutrophils were incubated in HBSS (-) alone (-) or with LPS for 60 min at 37°C. LPS, 0.01 ng/ml (A); 0.1 ng/ml (o); 1.0 ng/ml (o); 10 ng/ml (v); and 100 ng/ml (0). CaCl2, MgCl2, and MgSO4 salts were added in appropriate amounts to have a final solution equivalent to HBSS (+) and then stimulated with ionophore and incubated at 37°C. Incubations were terminated at predetermined time points by addition of 1.5 
Discussion
The results of these studies show that human neutrophils can be primed for enhanced production and release of LTB4 by exposure to picogram quantities of LPS. The time of incubation with LPS necessary for maximum enhancement of LTB4 production is 60 min. There is a significant effect seen at 30 min and a decreasing effect with prolonged incubation. An identical time course was found in studies of priming for superoxide generation (data not shown). The most potent stimuli for the production of LTB4 by neutrophils are the calcium ionophores (25, 26) . Incubation of human neutrophils with the ionophore at a concentration of 1.0 ,g/ml results in maximal production of LTB4. Enhancement of LTB4 production by LPS is not seen when the cells are maximally stimulated. Using a much lower concentration of ionophore (0.05 ,ug/ml), as little as 0.1 ng/ml of LPS is necessary to significantly enhance the production of LTB4 by neutrophils. LPS alone does not result in the release of detectable amounts of LTB4 by the neutrophils. The effect of LPS on the generation of LTB4 by ionophore-stimulated neutrophils is similar to increasing the concentration of ionophore. Prior incubation with LPS does not increase LTB4 production to a higher maximum. This suggests that the mechanism by which LPS is affecting LTB4 production might occur by modulation of cytosolic free calcium concentrations or by altering the activity of a calcium sensitive enzyme system. OZ stimulation of neutrophils has been shown to result in the production of very small amounts of LTB4 (25, 26) . The effect of OZ stimulation of neutrophils has been shown to be, at least in part, due to an increase in cytosolic free calcium (31). In the macrophage there also appears to be a calcium-dependent zymosan effect on phospholipase C, which may play a role in arachidonic acid release (32, 33) . Our studies confirm that OZ stimulation of neutrophils results in an increase in intracellular calcium. We have also found that OZ stimulation of neutrophils in the absence of extracellular calcium does not result in LTB4 production (data not shown). We did not find any significant effect of priming with LPS on this alteration in calcium levels. Coupled with the ionophore data this would seem to implicate a calcium dependent enzyme system as the likely site of action for LPS priming. There are multiple potential sights for this type of effect in the neutrophil including the phospholipases A2 and C (34), protein kinase C (35), phosphoinositol metabolism (36, 37) , and 5-lipoxygenase (38) . All of these systems have been implicated as being responsible for the differences in LTB4 production resulting from different stimuli.
The chemo-attractant tripeptide FMLP is reported to result in production of LTB4 by neutrophils only in the presence of a marked excess of arachidonate (25, 26) . Arachidonic acid at these concentrations has been postulated to be effecting either phospholipase C (26) or 5-lipoxygenase (25) activity directly, in addition to acting as substrate. FMLP acts at least in part by producing an increase in cytosolic free calcium which is brief and not sustained (39, 40 ) and also appears to have an effect on arachidonate mobilization and redistribution (41, 42) . It does not however result in metabolism of the arachidonic acid to LTB4. LPS does not potentiate production of LTB4 by neutrophils when FMLP is the second stimulant. The action of LPS in this system is therefore distinctly different than that ofexogenous arachidonic acid. 5-Lipoxygenase stimulation as the sole site of action for LPS would be unlikely and certainly would not explain previously described alterations in oxygen metabolism (1). These observations however do not rule out an LPS effect on 5-lipoxygenase and it is likely that a number of different sites could be affected.
It has been suggested that LPS enhances protein kinase C activity in neutrophils (43) and it seems reasonable to consider this a likely mechanism for the priming effect. PMA, a protein kinase C activator (44), has not been found to stimulate neutrophil production of LTB4, but has been shown to potentiate the production by ionophore stimulated neutrophils (29, 30) . Cells that are incubated with LPS and then with PMA produce LTB4 in significant amounts. The time course of PMA induced priming appears to differ from that of LPS priming of neutrophils. LPS requires a significant period of preincubation whereas PMA is effective when added simultaneously with ionophore. PMA also differs from LPS in its effect on LTB4 generation by OZ-stimulated neutrophils. LPS can prime for enhanced generation of LTB4 with OZ; PMA has been shown to have no effect (25) . The conditions under which PMA enhancement of LTB4 production by ionophore-stimulated neu-trophils occurs do have similarities with those necessary for priming by LPS. The PMA enhancement of LTB4 production by ionophore-stimulated neutrophils occurs with an ionophore concentration at which the effect of LPS can also be shown (29, 30) . PMA has been shown to actually decrease intracellular calcium or to not affect it at all (45, 46) . Our data shows no effect of LPS on cytosolic calcium concentrations. If the priming affect of LPS is via modulation ofprotein kinase C activity it is likely to be by a different mechanism than the PMA effect, since neither of these stimulants alone results in production of LTB4, but together they do. It seems most likely that their actions are similar but at separate sites, both ofwhich must be stimulated to result in production of LTB4 by the neutrophil. In macrophages LPS has been shown to cause the myristoylation of distinct membrane proteins with a temporal sequence similar to that required for priming of neutrophils (47) . One of these myristoylated proteins, with a relative molecular mass of68 kD, has been shown to be a protein kinase C substrate and to undergo membrane association and increased phosphorylation following LPS priming (48) . This is one possible explanation for the LPS effect that is consistent with our data. It is also possible that the LPS enhancement of LTB4 production is not via protein kinase C, but is a similar type of effect on another or several of the calcium-regulated enzyme systems involved in arachidonic acid liberalization and LTB4 production. In the macrophage, LPS not only enhances release of eicosanoids but decreases the lag phase between stimulation and eicosanoid release. Enhanced phospholipase activity has been postulated as a mechanism for this (3). Our observations in human neutrophils that not only LTB4 production is increased, but that the rate of this production is also increased with LPS priming are consistent with this hypothesis. Enhanced substrate availability or mobilization would certainly explain these findings.
In addition to having an effect on LTB4 production by neutrophils our data suggests that LPS priming may have an effect on LTB4 metabolism as well. Experiments with zymosan and ionophore A23187 (0.05 sg/ml) showed a marked difference in the percent of LTB4 present as metabolites between primed and unprimed neutrophils. Native LTB4 was present only in primed neutrophils, not controls when OZ was used as the stimulant. Native LTB4 was present as a greater percentage oftotal in LPS primed cells in the experiments with ionophore as the stimulant. This effect does not appear to be simply mass action as it is true when as little as 10 pg/ml LPS was used to prime the cells when there was no difference in actual production (data not shown). We also found no difference in intracellular retention of native LTB4 when separate extraction techniques were used for the supernatant and the cell pellet in contrast to what has been shown when unopsonized zymosan is used as a stimulant (17) . It would appear that LPS is in some way impairing the cells' mechanism for metabolizing LTB4 resulting in an apparent decrease rate of oxidation of native LTB4. Persistence of native LTB4 in the microenvironment may have a role in further amplification of the effects of increased production resulting from LPS priming.
LTB4 has been postulated to have a significant role in modulating host defense mechanisms (6) (7) (8) (9) (10) (11) 49) . The LPS-priming of human neutrophils for enhanced LTB4 production might play a role in immune response modulation during gram negative septicemia. This priming affect can be shown with as little as 0.1 ng/ml of LPS, an amount consistent with those measured in humans with septic shock. This is less than previously shown for priming for enhanced superoxide generation (1, 15) , or for priming of macrophages for enhanced eicosanoid release (3).
LTB4 has also been implicated in several types of pulmonary parenchymal injury (50) (51) (52) . Serious infections with gram negative bacteria are frequently complicated by the adult respiratory distress syndrome (ARDS), an illness characterized by a significant increase in pulmonary vascular permeability. This event is felt to be, at least in part, mediated by neutrophils (53) . If LPS primed neutrophils for enhanced LTB4 production in vivo, subsequent stimulation by activated complement proteins or by phagocytosis of pathogens might result in increased production and release of LTB4 into multiple tissues such as lung, kidney, liver and brain. The action of LTB4 as a cause ofneutrophil dependent increases in vascular permeability (12, 13) might play a significant role in the development of ARDS as well as multiple system organ failure. This latter syndrome has been recognized as one of the major causes of patient demise during human septic shock (54) .
